Sandoz

This study aims to see how long patients with Crohn's disease or ulcerative colitis (collectively called IBD) continue using the biosimilar medication Hyrimoz in real-world doctor's offices. Researchers will follow over 500 patients for up to a year to see if they stay on the tre…

This study aims to see if a new, proposed biosimilar drug called GME751 works similarly to the established drug Keytruda (pembrolizumab). It involves 322 adults with stage II or III melanoma who have had their cancer surgically removed. The goal is to prevent the cancer from retu…

This study compares a new biosimilar version of the cancer drug pembrolizumab (Keytruda) to the original drug in adults with untreated metastatic non-small cell lung cancer. Participants receive either the new biosimilar or the established drug, both combined with chemotherapy, t…